A distinct MSI phenotype with a low level of the MMR markers MSH3, MSH6, PMS1 and PMS2 is known as the MSI-Low (MSI-L) CRC subtype with a weak effect towards MMR system failure [3, 5, 6]. Here, PMS2 is linked to colorectal carcinoma.